According to brokerage China: Foreign media reports on the biosecurity law, US lawmakers are considering changes to the bill. The compromise version includes adding administrative review of relevant companies, rather than automatically banning biopharmaceutical companies from cooperating with Chinese companies. WuXi AppTec rose more than 5%, WuXi Bio rose more than 4%.